InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Nathanielsz James Andrew, Chief Financial Officer. Insider active across 1 company, notably Propanc Biopharma, Inc.. Aggregated, 1 reports have been recorded. History available since 17 August 2021. The latest transaction was disclosed on 17 August 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Nathanielsz James Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
5,928,000 shares0Common stock, par value $0.001SEC:0001493152-21-020758:0
1 of 1 declaration
About Nathanielsz James Andrew
James Andrew Nathanielsz is the CEO and CFO at Propanc Biopharma, Inc. In this dual role, he oversees the company's operations as well as its financial management. His expertise is crucial to ensure the viability and growth of Propanc.
